4th Quarter - Report

FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$23,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)

LobbyistCovered position, as disclosed
LILLIAN VERNE GERMAN Senior Counsel, House Judiciary Committee

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 2543 (116th), H.R. 133 (116th), S. 1461 (116th), H.R. 3 (116th), H.R. 2803 (116th), H.R. 2113 (116th), S. 2051 (116th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.